Modulation of fibronectin synthesis by cancer cell-fibroblast interaction: Cancer cells stimulate fibronectin production and affect alternative splicing of fibronectin pre-mRNA at EDA region in fibroblasts

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 721-730

  Inoue, Teruhiko ^a   Nabeshima, Kazuki ^a   Shimao, Yoshiya ^a   Kataoka, Hiroaki ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

cancer cell fibroblast interaction; EDA containing fibronectin; TGF

Indexed keywords

FIBRONECTIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECTUM CARCINOMA; TUMOR CELL LINE;

EID: 0029837299     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bissel MJ, Hall GH and Parry G: How does the extracellular matrix direct gene expression? J Theor Biol 99: 31-68, 1982.
2. Yamada KM: Fibronectin and other cell interactive glycoproteins. In: Cell Biology of Extracellular Matrix. Hay ED (ed.) New York, Plenum Press pp111-146, 1991.
3. Biswas C and Toole BP: Modulation of the extracellular matrix by tumor cell-fibroblast interactions. In: Cell Membranes: Methods and Reviews. Elson E, Frazier W and Glaser L (eds.) New York, Plenum Publ Corp. pp341-363, 1987.
4. Ruoslahti E: Fibronectin and its receptors. Annu Rev Biochem 57: 375-413, 1988.
5. Xia P and Culp LA: Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA) and its neighboring type III repeats: Oncogene-dependent regulation. Exp Cell Res 213: 253-265, 1994.
6. Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L and Virtanen I: Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88: 419-430, 1987.
7. Oyama F, Hirohashi S, Shimosato Y, Titani K and Sekiguchi K: Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J Biol Chem 264: 10331-10334, 1989.
8. Oyama F, Hirohashi S, Shimosato Y, Titani K and Sekiguchi K: Onco-developmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res 50: 1075-1078, 1990.
9. Oyama F, Hirohashi S, Sakamoto M, Titani K and Sekiguchi K: Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messcnger RNA at ED-A, ED-B, and CS1 regions in human liver tumors. Cancer Res 53: 2005-2011, 1993.
10. Ffrench-Constant C and Hynes RO: Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 106: 375-388, 1989.
11. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A and Natali PG: A Tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 108: 1139-1148, 1989.
12. London-Rosa B, Vielh P, Matsuura H, Clausen H, Cuadrado C and Burtin P: Distribution of oncofetal fibronectin in human mammary tumors: Immunofluorescence study on histological sections. Cancer Res 50: 1608-1612, 1990.
13. Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G and Zardi L: Distribution of oncofetal fibronectin isoforms in normal hyperplastic and neoplastic human breast tissues. Int J Cancer 58: 11-16, 1994.
14. + mRNA isoforms: Molecular markers for hepatocellular carcinoma. Int J Cancer 56: 820-825, 1994.
15. Natali PG, Nicotra MR, Di Filippo F and Bigotti A: Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer 71: 1243-1247, 1995.
16. Kurogi T, Nabeshima K, Kataoka H, Okada Y and Koono M: Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: Gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int J Cancer 66: 82-90, 1996.
17. Kataoka H, Nabeshima K, Komada N and Koono M: New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro. Virchows Arch (B) 57: 157-165, 1989.
18. Jiang WG, Puntis MCA and Hallett MB: Monocyte-conditioned media possess a novel factor which increases motility of cancer cells. Int J Cancer 53: 426-431, 1993.
19. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162: 156-159, 1987.
20. Magnuson VL, Young M, Schattenberg DG, Mancini MA, Chen D, Steffensen B and Klebe RJ: The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 266: 14654-14662, 1991.
21. Lüscher U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M and Spagnoli GC: The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57: 612-619, 1994.
22. Lerat H, Lissitzky JC, Singer JW, Keating A, Herve P and Charbord P: Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures. Blood 82: 1480-1492, 1993.
23. Wu C, Chung AE, McDonald JA: A novel role for α3β1 integrins in extracellular matrix assembly. J Cell Sci 108: 2511-2523, 1995.
24. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
25. Engvall E and Ruoslahti E: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20: 1-5, 1977.
26. McKay NG, Hunter DJ, Haites NE and Power DA: Regulation of alternative splicing of the fibronectin IIICS domain by cytokines. Biochem Biophys Res Commun 199: 1005-1011, 1994.
27. Balza E, Borsi L, Allemanni G and Zardi L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228: 42-44, 1988.
28. Kawamoto M, Romberger DJ, Nakamura Y, Adachi Y, Tate L, Ertl RF, Spurzem JR and Rennard SI: Modulation of fibroblast type I collagen and fibronectin production by bovine bronchial epithelial cells. Am J Respir Cell Mol Biol 12: 425-433, 1995.
29. Lohi J, Tani T, Laitinen L, Kangas L, Lehto VP and Virtanen I: Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice. Int J Cancer 63: 442-449, 1995.
30. Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L, Castellucci M, Klosterhalfen B, Hartung P, Weis J, Stocker G, Haubeck HD and Kirkpatrick CJ: Extracellular matrix protein in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest 73: 172-182, 1995.
31. Nabeshima K, Kishi J, Kurogi T, Komada N, Kataoka H, Okada Y and Koono M: Stimulation of TIMP-1 and metalloproteinase production in co-cultures of human tumor cells and human fibroblasts. Cancer Lett 78: 133-140, 1994.
32. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H and Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439, 1995.
33. Cai X, Foster CS, Liu JJ, Kupferman AE, Filipec M, Colvin RB and Lee SJ: Alternatively spliced fibronectin molecules in the wounded cornea: Analysis by PCR. Invest Ophthalmol Vis Sci 34: 3585-3592, 1993.
34. Guan JL, Trevithick JE and Hynes RO: Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol 110: 833-847, 1990.
35. Xia P and Culp LA: Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): Complementarity to plasma fibronectin functions. Exp Cell Res 217: 517-527, 1995.
36. Saiki I, Murata J, Yoneda J, Kobayashi H, and Azuma I: Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J Cancer 56: 867-873, 1994.
37. + isoforms by human and experimental colorectal cancer: Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol 148: 579-592, 1996.